7RA9 image
Entry Detail
PDB ID:
7RA9
Keywords:
Title:
Designed StabIL-2 seq1
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2021-06-30
Release Date:
2022-03-16
Method Details:
Experimental Method:
Resolution:
2.20 Å
R-Value Free:
0.29
R-Value Work:
0.25
R-Value Observed:
0.25
Space Group:
P 65 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Interleukin-2
Mutations:G27M, I28L, K32D, M39L, E52S, V69A, L72A, Q74G, S75D, K76D, N77P, F78K, H79T, L80I, delta81-82, L85V, I86V, I92F, V115I
Chain IDs:A
Chain Length:132
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Interleukin-2 superkines by computational design.
Proc.Natl.Acad.Sci.USA 119 e2117401119 e2117401119 (2022)
PMID: 35294290 DOI: 10.1073/pnas.2117401119

Abstact

Affinity maturation of protein–protein interactions is an important approach in the development of therapeutic proteins such as cytokines. Typical experimental strategies involve targeting the cytokine-receptor interface with combinatorial libraries and then selecting for higher-affinity variants. Mutations to the binding scaffold are usually not considered main drivers for improved affinity. Here we demonstrate that computational design can provide affinity-enhanced variants of interleukin-2 (IL-2) “out of the box” without any requirement for interface engineering. Using a strategy of global IL-2 structural stabilization targeting metastable regions of the three-dimensional structure, rather than the receptor binding interfaces, we computationally designed thermostable IL-2 variants with up to 40-fold higher affinity for IL-2Rβ without any library-based optimization. These IL-2 analogs exhibited CD25-independent activities on T and natural killer (NK) cells both in vitro and in vivo, mimicking the properties of the IL-2 superkine “super-2” that was engineered through yeast surface display [A. M. Levin et al., Nature, 484, 529–533 (2012)]. Structure-guided stabilization of cytokines is a powerful approach to affinity maturation with applications to many cytokine and protein–protein interactions.

Legend

Protein

Chemical

Disease

Primary Citation of related structures